EBIT Margin: Earnings before interest and taxes as a portion of total revenues. Calculated as: EBIT / Total Revenues
Xenetic Biosciences, Inc. (XBIO) had EBIT Margin of -169.41% for the most recently reported fiscal quarter, ending 2024-12-31.
| Income Statement Financials | |
$0.65M |
|
$-1.05M |
|
-- |
|
$0.65M |
|
$1.75M |
|
$-1.10M |
|
$0.04M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.05M |
|
$-1.10M |
|
$-1.10M |
|
1.54M |
|
1.54M |
|
$-0.68 |
|
$-0.68 |
|
| Balance Sheet Financials | |
$6.59M |
|
-- |
|
$0.31M |
|
$6.90M |
|
$0.89M |
|
-- |
|
-- |
|
$0.89M |
|
$6.01M |
|
$6.01M |
|
$6.01M |
|
1.54M |
|
| Cash Flow Statement Financials | |
$-2.82M |
|
-- |
|
-- |
|
$8.98M |
|
$6.17M |
|
$-2.82M |
|
$0.17M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
7.37 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-169.41% |
|
|
EBIT Margin |
-169.41% |
-- |
|
-162.53% |
|
-162.53% |
|
$-2.82M |
|
-- |
|
-- |
|
-- |
|
0.09 |
|
-- |
|
-- |
|
-- |
|
-17.56% |
|
-17.55% |
|
-15.28% |
|
-17.55% |
|
$3.90 |
|
$-1.83 |
|
$-1.83 |
|